Meeting of the National Advisory Council for Healthcare Research and Quality, 8482 [2018-03926]

Download as PDF 8482 Federal Register / Vol. 83, No. 39 / Tuesday, February 27, 2018 / Notices B. What are the equipment parameters that are necessary to achieve desired outcomes (e.g. flow capabilities, settings, etc.)? C. What are the parameters of prescribed patient usage (e.g. frequency of use, duration of use throughout the day, other)? D. In each of the above populations, what are the parameters of patient compliance with the prescribed usage of the equipment? IV. What respiratory services, other than the technical support of the use of the prescribed equipment, are being provided to the above patients in the home (e.g. patient education, ongoing smoking cessation, respiratory therapist led home care)? V. What are the professional guidelines and statements which address KQ 1 to KQ 4? PICOTS (Populations, Interventions, Comparators, Outcomes, Timing, Settings) daltland on DSKBBV9HB2PROD with NOTICES Interventions I. Home mechanical ventilators (FDAapproved only) with or without pertinent ancillary in-home services (e.g. respiratory therapy in the home; pharmacy reconciliation; smoking cessation, etc.) II. BPAP respiratory assist devices (FDA-approved only) w/or w/o pertinent ancillary in-home services III. CPAP respiratory assist devices (FDA-approved only) w/or w/o pertinent ancillary in-home services Comparators I. Usual care (i.e. no mechanical ventilation/BPAP/CPAP) II. Different type of noninvasive mechanical ventilation III. Different modes of same equipment IV. Other noninvasive ventilation (Studies without a comparator treatment that evaluate the effect of a patient characteristic, laboratory criteria, ventilator parameter, or respiratory services on outcomes of interest will be included) Patient-Centered Outcomes I. Mortality VerDate Sep<11>2014 19:49 Feb 26, 2018 Jkt 244001 Timing Rockville, Maryland, 20857, (301) 427– 1456. For press-related information, please contact Alison Hunt at (301) 427– 1244 or at Alison.Hunt@ahrq.hhs.gov. Closed captioning will be provided during the WebEx. If another accommodation for a disability is needed, please contact the Food and Drug Administration (FDA) Office of Equal Employment Opportunity and Diversity Management on (301) 827– 4840, no later than Friday, March 9, 2018. I. At least 1 month of treatment SUPPLEMENTARY INFORMATION: Setting I. Purpose I. Home II. Assisted living residence The National Advisory Council for Healthcare Research and Quality is authorized by Section 941 of the Public Health Service Act, 42 U.S.C. 299c. In accordance with its statutory mandate, the Council is to advise the Secretary of the Department of Health and Human Services and the Director of AHRQ on matters related to AHRQ’s conduct of its mission including providing guidance on (A) priorities for health care research, (B) the field of health care research including training needs and information dissemination on health care quality and (C) the role of the Agency in light of private sector activity and opportunities for public private partnerships. The Council is composed of members of the public, appointed by the Secretary, and Federal ex-officio members specified in the authorizing legislation. Publication Time I. From 1995 Subgroup Analysis Population(s) I. Adults 18 years and older with chronic respiratory failure due to: A. Neuromuscular diseases B. Thoracic restrictive diseases (including thoracic cage abnormalities and morbid obesity) C. Chronic obstructive pulmonary disease D. Other lung diseases (cystic fibrosis, bronchiectasis) Outcomes II. Hospitalization III. Admission/readmission to intensive care unit (ICU) IV. Need for intubation V. Outpatient visits VI. Emergency room visits VII. Disease exacerbations VIII. Quality of life (QoL) IX. Activities of daily living (ADL) X. Dyspnea XI. Sleep quality XII. Exercise tolerance XIII. Adverse events I. Type of diseases A. Neuromuscular diseases B. Thoracic restrictive diseases i. Thoracic cage abnormalities ii. Morbid obesity C. COPD D. Other lung diseases (cystic fibrosis, bronchiectasis) II. Length of treatment (1 month, 3 months, 6 months and longer) Karen J. Migdail, Chief of Staff. [FR Doc. 2018–03927 Filed 2–26–18; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Meeting of the National Advisory Council for Healthcare Research and Quality Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of public meeting. AGENCY: This notice announces a meeting of the National Advisory Council for Healthcare Research and Quality. SUMMARY: The meeting will be held on Friday, March 16, 2018, from 11:00 a.m. to 1:00 p.m. (EST). ADDRESSES: The meeting will be held virtually (via WebEx). FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management Official, at the Agency for Healthcare Research and Quality, 5600 Fishers Lane, Mail Stop 06E37A, DATES: PO 00000 Frm 00065 Fmt 4703 Sfmt 9990 II. Agenda On Friday, March 16, 2018, the Council meeting will convene via WebEx at 11:00 a.m. (EST), with the call to order by the Council Chair and approval of previous Council summary notes. The agenda will include an update by the AHRQ Director and an update on the Healthcare Cost and Utilization Project (HCUP) new release of county level statistics on hospital stays for alcohol, opioids, and other drugs. The meeting is open to the public. For information regarding how to access the WebEx as well as other meeting details, please go to https:// www.ahrq.gov/news/events/nac/. Karen J. Migdail, Chief of Staff. [FR Doc. 2018–03926 Filed 2–26–18; 8:45 am] BILLING CODE 4160–90–P E:\FR\FM\27FEN1.SGM 27FEN1

Agencies

[Federal Register Volume 83, Number 39 (Tuesday, February 27, 2018)]
[Notices]
[Page 8482]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-03926]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Meeting of the National Advisory Council for Healthcare Research 
and Quality

AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a meeting of the National Advisory 
Council for Healthcare Research and Quality.

DATES: The meeting will be held on Friday, March 16, 2018, from 11:00 
a.m. to 1:00 p.m. (EST).

ADDRESSES: The meeting will be held virtually (via WebEx).

FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management 
Official, at the Agency for Healthcare Research and Quality, 5600 
Fishers Lane, Mail Stop 06E37A, Rockville, Maryland, 20857, (301) 427-
1456. For press-related information, please contact Alison Hunt at 
(301) 427-1244 or at [email protected]. Closed captioning will 
be provided during the WebEx. If another accommodation for a disability 
is needed, please contact the Food and Drug Administration (FDA) Office 
of Equal Employment Opportunity and Diversity Management on (301) 827-
4840, no later than Friday, March 9, 2018.

SUPPLEMENTARY INFORMATION: 

I. Purpose

    The National Advisory Council for Healthcare Research and Quality 
is authorized by Section 941 of the Public Health Service Act, 42 
U.S.C. 299c. In accordance with its statutory mandate, the Council is 
to advise the Secretary of the Department of Health and Human Services 
and the Director of AHRQ on matters related to AHRQ's conduct of its 
mission including providing guidance on (A) priorities for health care 
research, (B) the field of health care research including training 
needs and information dissemination on health care quality and (C) the 
role of the Agency in light of private sector activity and 
opportunities for public private partnerships. The Council is composed 
of members of the public, appointed by the Secretary, and Federal ex-
officio members specified in the authorizing legislation.

II. Agenda

    On Friday, March 16, 2018, the Council meeting will convene via 
WebEx at 11:00 a.m. (EST), with the call to order by the Council Chair 
and approval of previous Council summary notes. The agenda will include 
an update by the AHRQ Director and an update on the Healthcare Cost and 
Utilization Project (HCUP) new release of county level statistics on 
hospital stays for alcohol, opioids, and other drugs. The meeting is 
open to the public. For information regarding how to access the WebEx 
as well as other meeting details, please go to https://www.ahrq.gov/news/events/nac/.

Karen J. Migdail,
Chief of Staff.
[FR Doc. 2018-03926 Filed 2-26-18; 8:45 am]
 BILLING CODE 4160-90-P